Literature DB >> 6880403

Influence of nonsteroidal anti-inflammatory agents on lapine articular chondrocyte growth in vitro.

C J Kirkpatrick, W Mohr, A Mildfeuer, O Haferkamp.   

Abstract

The lapine articular chondrocyte monolayer was used to study the effects of cell proliferation, morphology, nd synthesis of proteoglycans of four nonsteroidal anti-inflammatory agents piroxicam, diclofenac sodium, sulindac sulfiphe, and indomethacin. None of the substances caused any alteration to chondrocyte morphology. Cell proliferation and macromolecular binding of 35SO4 were unaffected by piroxicam (0.2, 2, and 20 micrograms/ml) or diclofenac sodium (0.2, 2, and 5 micrograms/ml). Whereas indomethacin markedly reduced cell proliferation (100 mumol/l; p less than 0.01), it failed to alter net proteoglycan synthesis significantly (1, 10, and 100 mumol/l). Sulindac sulfiphe significantly reduced chondrocyte proliferation at 0.5 and 5 micrograms/ml (p less than 0.01). The 0.5 micrograms/ml concentration also markedly stimulated proteoglycan synthesis (171%; p less than 0.01). The use of the articular chondrocyte monolayer as an experimental model to investigate drug-induced alterations of cartilage metabolism is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6880403

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  6 in total

1.  Effects of sodium naproxen on differentiated human chondrocytes cultivated in clusters.

Authors:  C Bassleer; Y Henrotin; P Franchimont
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

2.  Effects of etodolac on human chondrocytes cultivated in three dimensional culture.

Authors:  Y Henrotin; C Bassleer; J Y Reginster; P Franchimont
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

3.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.

Authors:  S J Shiff; L Qiao; L L Tsai; B Rigas
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  A comparison of the effects of two gold-containing therapeutic agents on articular chondrocyte growth in vitro.

Authors:  C J Kirkpatrick; W Mohr
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

5.  Effect of piroxicam on structure and function of joint cartilage.

Authors:  W Mohr; C J Kirkpatrick; A Wildfeuer; M Leitold
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

6.  International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.

Authors:  D Briancon
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.